GENE:EGLN2
GeneInfo:
| GeneAttribute | GeneDescription |
|---|---|
| GeneSymbol | EGLN2 |
| FullNmae | egl-9 family hypoxia inducible factor 2 |
| LocusType | gene with protein product |
| Status | Approved |
| HGNC_id | HGNC:14660 |
| EnsembleID | ENSG00000269858 |
| Uniprot | Q96KS0 |
Protein Structure:
Gene Description in Publicaton:
| GeneSymbol | CellDeathType | PMID | Description | GeneType |
|---|---|---|---|---|
| EGLN2 | ferroptosis | 38538696 | The 18 RCD signatures collected from previous studies. Supplementary Table of Figures.xlsx (https://github.com/zwxiangya/RCDscore) | retulator signature |
| EGLN2 | autosis | 38538696 | The 18 RCD signatures collected from previous studies. Supplementary Table of Figures.xlsx (https://github.com/zwxiangya/RCDscore) | retulator signature |
Go Annotation:
| GeneSymbol | Go id |
|---|---|
| EGLN2 | GO:0001558,GO:0001666,GO:0005515,GO:0005634,GO:0005634,GO:0005654,GO:0005654,GO:0005737,GO:0008198,GO:0008198,GO:0008198,GO:0016706,GO:0018401,GO:0018401,GO:0019826,GO:0030520,GO:0031418,GO:0031545,GO:0031545,GO:0043523,GO:0045454,GO:0045732,GO:0071456 |
KEGG Annotation:
| GeneSymbol | GeneID | Pathway | Pathway Name |
|---|---|---|---|
| EGLN2 | hsa:112398 | path:hsa04066 | HIF-1 signaling pathway - Homo sapiens (human) |
| EGLN2 | hsa:112398 | path:hsa05200 | Pathways in cancer - Homo sapiens (human) |
| EGLN2 | hsa:112398 | path:hsa05211 | Renal cell carcinoma - Homo sapiens (human) |
Protein-Protein Interaction(String):
Signalink 3.0 modificators
| Source | Target | Pmid | Interactiontype | Methods | Database |
|---|---|---|---|---|---|
| AR | EGLN2 | 20610535 | trascriptional regulation,stimulation | chromatin immunoprecipitation array | TFlink |
| ESR1 | EGLN2 | 18414489 | trascriptional regulation,stimulation | chromatin immunoprecipitation array | TFlink |
| ETS1 | EGLN2 | 18971253 20019798 | trascriptional regulation,stimulation | inferred by curator,chromatin immunoprecipitation assay | TFlink |
| GATA2 | EGLN2 | 19941826 | trascriptional regulation,stimulation | chromatin immunoprecipitation assay | TFlink |
| YBX1 | EGLN2 | 19151767 | trascriptional regulation,stimulation | chromatin immunoprecipitation assay | TFlink |
| TP73 | EGLN2 | 19558638 | trascriptional regulation,stimulation | chromatin immunoprecipitation array | TFlink |
| CEBPA | EGLN2 | 18971253 | trascriptional regulation,stimulation | inferred by curator | TFlink |
| CTCF | EGLN2 | 18971253 | trascriptional regulation,stimulation | inferred by curator | TFlink |
| E2F1 | EGLN2 | 18971253 | trascriptional regulation,stimulation | inferred by curator | TFlink |
| E2F4 | EGLN2 | 18971253 | trascriptional regulation,stimulation | inferred by curator | TFlink |
| EGR1 | EGLN2 | 18971253 | trascriptional regulation,stimulation | inferred by curator | TFlink |
| FOXP1 | EGLN2 | 18971253 | trascriptional regulation,stimulation | inferred by curator | TFlink |
| HNF4A | EGLN2 | 18971253 | trascriptional regulation,stimulation | inferred by curator | TFlink |
| MITF | EGLN2 | 18971253 | trascriptional regulation,stimulation | inferred by curator | TFlink |
| VDR | EGLN2 | 18971253 | trascriptional regulation,stimulation | inferred by curator | TFlink |
| ARNT | EGLN2 | 15178343 | trascriptional regulation,stimulation | inferred by curator | TFlink |
| Source | Target | Pmid | Interactiontype | Methods | Database |
|---|---|---|---|---|---|
| URS0000016914 | EGLN2 | 22859986 25416803 | mrna cleavage,inhibition | array technology,western blot,quantitative reverse transcription pcr,miRNA interference luciferase reporter assay | TarBase |
| URS0000204177 | EGLN2 | 19536157 25416803 | mrna cleavage,inhibition | clip | TarBase |
| URS0000224AEA | EGLN2 | 19536157 25416803 | mrna cleavage,inhibition | clip | TarBase |
| Source | Target | Pmid | Interactiontype | Methods | Database |
|---|---|---|---|---|---|
| GSK3B | EGLN2 | 22135298 | phosphorylation | N/A | PhosphoSite |
| CDK2 | EGLN2 | 22135298 | phosphorylation | N/A | PhosphoSite |
| CDK4 | EGLN2 | 22135298 | phosphorylation | N/A | PhosphoSite |
| CDK6 | EGLN2 | 22135298 | phosphorylation | N/A | PhosphoSite |
| PRKCA | EGLN2 | 22135298 | phosphorylation | N/A | PhosphoSite |
| Source | Target | Pmid | Interactiontype | Methods | Database |
|---|---|---|---|---|---|
| SPRY2 | EGLN2 | 25348397 | N/A | physical interaction | ComPPI |
| EGLN3 | EGLN2 | 25348397 | N/A | physical interaction | ComPPI |
| SIAH2 | EGLN2 | 25348397 | N/A | physical interaction | ComPPI |
| FBXW7 | EGLN2 | 25348397 | N/A | physical interaction | ComPPI |
| HIF1A | EGLN2 | 11292861 11292862 14525934 15474027 16511565 17353276 24234451 25348397 | hydroxylation reaction,physical association | anti bait coimmunoprecipitation,experimental interaction detection,pull down,physical interaction,in vitro,in vivo | ComPPI,HPRD,IntAct |
| CUL3 | EGLN2 | 25348397 | N/A | physical interaction | ComPPI |
| TRIP6 | EGLN2 | 25348397 | N/A | physical interaction | ComPPI |
| DYRK1B | EGLN2 | 25348397 | N/A | physical interaction | ComPPI |
| VHL | EGLN2 | 25348397 | N/A | two hybrid | ComPPI |
| TENT5A | EGLN2 | 14525934 15231748 25348397 | N/A | two hybrid,physical interaction,two hybrid | ComPPI,HPRD |
| POLR2A | EGLN2 | 25348397 | N/A | physical interaction | ComPPI |
| AJUBA | EGLN2 | 25348397 | N/A | physical interaction | ComPPI |
| HIF3A | EGLN2 | 14525934 15474027 25348397 | N/A | experimental interaction detection,in vitro | ComPPI,HPRD |
| LPP | EGLN2 | 25348397 | N/A | physical interaction | ComPPI |
| TRIM25 | EGLN2 | 25348397 | N/A | physical interaction | ComPPI |
| SPOP | EGLN2 | 25348397 | N/A | physical interaction | ComPPI |
| SRPK2 | EGLN2 | 23602568 24234451 25348397 | phosphorylation reaction | physical interaction,protein kinase assay | ComPPI,IntAct |
| MOB4 | EGLN2 | 14525934 16169070 24234451 25348397 | physical association | two hybrid,two hybrid pooling approach,two hybrid fragment pooling approach,two hybrid | ComPPI,HPRD,IntAct |
| EPAS1 | EGLN2 | 14525934 15474027 17353276 24234451 25348397 | physical association | experimental interaction detection,pull down,physical interaction,in vitro | ComPPI,HPRD,IntAct |
| EGLN2 | PRPF19 | 25348397 | N/A | physical interaction | ComPPI |
| EGLN2 | LIMD1 | 25348397 | N/A | physical interaction | ComPPI |
| EGLN2 | WTIP | 25348397 | N/A | physical interaction | ComPPI |
| EGLN2 | MAGEA11 | 25348397 | N/A | physical interaction | ComPPI |
| EGLN2 | A2M | 25348397 | N/A | physical interaction | ComPPI |
| EGLN2 | CEP192 | 25348397 | N/A | physical interaction | ComPPI |
| EGLN2 | DYRK1A | 25348397 | N/A | physical interaction | ComPPI |
| EGLN2 | MFHAS1 | 24234451 25348397 29513927 | N/A | protein array | ComPPI,IntAct |
| PRKCA | EGLN2 | 18710826 27898060 | inhibition | N/A | OmniPath |
| HIF1A | EGLN2 | 11292861 11292862 15474027 16511565 17353276 18264140 24145445 27898060 | N/A | N/A | OmniPath |
| EGLN2 | HIF1A | 11292861 11292862 15474027 16391536 16511565 17353276 18264140 24145445 27898060 | inhibition,stimulant | N/A | OmniPath |
